001     142210
005     20240229105147.0
024 7 _ |2 doi
|a 10.1093/jnci/djx286
024 7 _ |2 pmid
|a pmid:29518203
024 7 _ |2 pmc
|a pmc:PMC6093439
024 7 _ |2 ISSN
|a 0027-8874
024 7 _ |2 ISSN
|a 0198-0157
024 7 _ |2 ISSN
|a 1460-2105
024 7 _ |a altmetric:34158604
|2 altmetric
037 _ _ |a DKFZ-2019-00024
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Yu, Danxia
|b 0
245 _ _ |a Overall and Central Obesity and Risk of Lung Cancer: A Pooled Analysis.
260 _ _ |a Oxford
|b Oxford Univ. Press
|c 2018
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1549621982_21015
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
336 7 _ |0 0
|2 EndNote
|a Journal Article
520 _ _ |a The obesity-lung cancer association remains controversial. Concerns over confounding by smoking and reverse causation persist. The influence of obesity type and effect modifications by race/ethnicity and tumor histology are largely unexplored.We examined associations of body mass index (BMI), waist circumference (WC), and waist-hip ratio (WHR) with lung cancer risk among 1.6 million Americans, Europeans, and Asians. Cox proportional hazard regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) with adjustment for potential confounders. Analyses for WC/WHR were further adjusted for BMI. The joint effect of BMI and WC/WHR was also evaluated.During an average 12-year follow-up, 23 732 incident lung cancer cases were identified. While BMI was generally associated with a decreased risk, WC and WHR were associated with increased risk after controlling for BMI. These associations were seen 10 years before diagnosis in smokers and never smokers, were strongest among blacks, and varied by histological type. After excluding the first five years of follow-up, hazard ratios per 5 kg/m2 increase in BMI were 0.95 (95% CI = 0.90 to 1.00), 0.92 (95% CI = 0.89 to 0.95), and 0.89 (95% CI = 0.86 to 0.91) in never, former, and current smokers, and 0.86 (95% CI = 0.84 to 0.89), 0.94 (95% CI = 0.90 to 0.99), and 1.09 (95% CI = 1.03 to 1.15) for adenocarcinoma, squamous cell, and small cell carcinoma, respectively. Hazard ratios per 10 cm increase in WC were 1.09 (95% CI = 1.00 to 1.18), 1.12 (95% CI = 1.07 to 1.17), and 1.11 (95% CI = 1.07 to 1.16) in never, former, and current smokers, and 1.06 (95% CI = 1.01 to 1.12), 1.20 (95% CI = 1.12 to 1.29), and 1.13 (95% CI = 1.04 to 1.23) for adenocarcinoma, squamous cell, and small cell carcinoma, respectively. Participants with BMIs of less than 25 kg/m2 but high WC had a 40% higher risk (HR = 1.40, 95% CI = 1.26 to 1.56) than those with BMIs of 25 kg/m2 or greater but normal/moderate WC.The inverse BMI-lung cancer association is not entirely due to smoking and reverse causation. Central obesity, particularly concurrent with low BMI, may help identify high-risk populations for lung cancer.
536 _ _ |0 G:(DE-HGF)POF3-313
|a 313 - Cancer risk factors and prevention (POF3-313)
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Zheng, Wei
|b 1
700 1 _ |a Johansson, Mattias
|b 2
700 1 _ |a Lan, Qing
|b 3
700 1 _ |a Park, Yikyung
|b 4
700 1 _ |a White, Emily
|b 5
700 1 _ |a Matthews, Charles E
|b 6
700 1 _ |a Sawada, Norie
|b 7
700 1 _ |a Gao, Yu-Tang
|b 8
700 1 _ |a Robien, Kim
|b 9
700 1 _ |a Sinha, Rashmi
|b 10
700 1 _ |a Langhammer, Arnulf
|b 11
700 1 _ |0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|a Kaaks, Rudolf
|b 12
|u dkfz
700 1 _ |a Giovannucci, Edward L
|b 13
700 1 _ |a Liao, Linda M
|b 14
700 1 _ |a Xiang, Yong-Bing
|b 15
700 1 _ |a Lazovich, DeAnn
|b 16
700 1 _ |a Peters, Ulrike
|b 17
700 1 _ |a Zhang, Xuehong
|b 18
700 1 _ |a Bueno-de-Mesquita, Bas
|b 19
700 1 _ |a Willett, Walter C
|b 20
700 1 _ |a Tsugane, Shoichiro
|b 21
700 1 _ |a Takata, Yumie
|b 22
700 1 _ |a Smith-Warner, Stephanie A
|b 23
700 1 _ |a Blot, William
|b 24
700 1 _ |a Shu, Xiao-Ou
|b 25
773 _ _ |0 PERI:(DE-600)1465951-7
|a 10.1093/jnci/djx286
|g Vol. 110, no. 8, p. 831 - 842
|n 8
|p 831 - 842
|t Journal of the National Cancer Institute
|v 110
|x 1460-2105
|y 2018
909 C O |o oai:inrepo02.dkfz.de:142210
|p VDB
910 1 _ |0 I:(DE-588b)2036810-0
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|a Deutsches Krebsforschungszentrum
|b 12
|k DKFZ
913 1 _ |0 G:(DE-HGF)POF3-313
|1 G:(DE-HGF)POF3-310
|2 G:(DE-HGF)POF3-300
|a DE-HGF
|l Krebsforschung
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2018
915 _ _ |0 StatID:(DE-HGF)0420
|2 StatID
|a Nationallizenz
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b JNCI-J NATL CANCER I : 2017
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
915 _ _ |0 StatID:(DE-HGF)0310
|2 StatID
|a DBCoverage
|b NCBI Molecular Biology Database
915 _ _ |0 StatID:(DE-HGF)0320
|2 StatID
|a DBCoverage
|b PubMed Central
915 _ _ |0 StatID:(DE-HGF)0600
|2 StatID
|a DBCoverage
|b Ebsco Academic Search
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b ASC
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
915 _ _ |0 StatID:(DE-HGF)0110
|2 StatID
|a WoS
|b Science Citation Index
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
915 _ _ |0 StatID:(DE-HGF)0111
|2 StatID
|a WoS
|b Science Citation Index Expanded
915 _ _ |0 StatID:(DE-HGF)1110
|2 StatID
|a DBCoverage
|b Current Contents - Clinical Medicine
915 _ _ |0 StatID:(DE-HGF)1030
|2 StatID
|a DBCoverage
|b Current Contents - Life Sciences
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
915 _ _ |0 StatID:(DE-HGF)9910
|2 StatID
|a IF >= 10
|b JNCI-J NATL CANCER I : 2017
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l Epidemiologie von Krebserkrankungen
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21